Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

As a man over the age of 50 who has been treated for cancer, I may not be the most impartial witness when it comes to the ...

Learn more about prostate cancer and why there is a debate over whether or not patients should get tested for it.

Nigeria may soon become a medical tourism destination of choice for prostate treatment, following a historic medical ...

A new study suggests cholesterol-lowering statins, when combined with apalutamide and hormone therapy, can significantly ...

Teasing for gynaecomastia (enlarged male breast tissue) will unfortunately be familiar for many men and boys. But it's far ...

UroLift is a minimally invasive treatment for Benign Prostatic Hyperplasia, a condition that causes an enlarged prostate in ...

SBRT may ease toxicity, but the lower doses could come at the expense of cancer control, new data indicate. Experts suggest a ...

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

A common painkiller taken by millions could have cancer fighting properties, slashing the risk of womb, bowel, lung and ...

At 72, Judith McDaniel, a former oncology nurse, experienced cancer treatment after a routine mammogram led to her diagnosis ...